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Introduction Periodontitis	  Innate	  immunity	  TLR2	  in	  Porphyromonas	  gingivalis	  recognition	  	  Heterogeneity	  in	  periodontal	  disease	  susceptibility	  Epigenetics	  of	  innate	  immunity	  DNA	  Methylation	  
 
Infectious and inflammatory diseases affect millions of people in the United States.  A large 
percentage of patients are either killed or debilitated by infectious diseases.  Periodontitis is 
a chronic infectious, destructive disease of the gingival tissues supporting the teeth. It begins 
when the bacteria in plaque, the microbial biofilm, causes the gums to become inflamed. If 
untreated, this disease can lead to severe tooth loss and may interact with other systemic 
health problems increasing morbidity and mortality1. It affects more than ~70% of the 
population, causing significant debilitation for the affected population and imposes a major 
economic burden to the United States2.  This disease is very complex in nature that affects 
not only soft gum tissue but also affects hard bone. A recent report from the American 
Dental Association claims $100 billion in dental spending per year, estimated to reach 
nearly $179 billion by 2021. Over the past three decades, research has shown, and experts 
comply, that there is an association between periodontal diseases and other chronic 
inflammatory conditions, such as diabetes, cardiovascular and Alzheimer’s disease, stroke, 
osteoporosis, respiratory diseases and pregnancy problems including pre-term birth3-10 . 
Therefore, treating periodontal inflammation may not only help manage periodontal 
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diseases but may also help with the management of other chronic inflammatory conditions 
in general. 
There are two major forms of periodontitis, chronic and aggressive11,12. Epidemiologic 
studies have concluded that chronic periodontitis is the most commonly occurring form of 
periodontal disease with most subjects experiencing moderate amounts of periodontal tissue 
destruction. A recent study in United state shows over 47%, American adults ≥30 years, 
have periodontitis, 8.7% mild, 30.0% moderate, and 8.5% severe periodontitis2. 
The periodontitis is initiated by microbial plaque, which accumulates in the gingival crevice 
and induces an inflammatory response13. Initial inflammation is reversible and could 
progress in susceptible individuals to a chronic destructive inflammatory condition, in which 
tooth supporting tissue are destroyed. For years identifying micro-organisms associated with 
periodontal disease or health were limited to those which could be cultured under laboratory 
conditions. Indeed, classification of the periodontal microbiota by culturing techniques in 
the late 1970s and early 1980s created a dramatic change in our understanding of bacterial 
composition of disease compared to health14-18.  Socransky et al. classified bacteria into six 
groups based on different potential pathogenicity and their role in the development of 
plaque, categorized by colors. “red complex”, which is a group of three Gram-negative 
anaerobic bacteria, includes Porphyromonas gingivalis, Treponema denticola, and 
Tannerella forsythia. The “orange complex” comprised species members of the genus 
Prevotella, Fusobacterium, and Campylobacter, Streptococcus constellatus and 
Eubacterium nodatum. The other four complexes (“blue”, “yellow”, “green”, and “purple”) 
primarily consisted of early colonizers of the tooth surfaces19. 
Recent developments in molecular-methodologies of bacterial identification, for example 
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16S rRNA amplification and high-throughput sequencing, have revolutionized the 
understanding of the composition of the periodontal microbiota20 . The study of thousands of 
plaque samples derived from multiple clinical periodontal conditions has demonstrated a 
more heterogeneous and diverse periodontal microbiota than previously thought. Newly 
recognized non or poorly cultivable organisms that increase in number in diseased sites 
include the Gram-positive Filifactor alocis and species in the genera Prevotella, 
Megasphaera, Selenomonas, and Desulfobulbus. Many of these organisms show similar 
correlation with disease as red complex21, 22 . 
Chronic periodontitis is the result of a poly-microbial induced breakdown of host 
homeostasis in susceptible individuals, not just a bacterial infection caused by a single or a 
limited number of pathogens23. The host reacts to this poly-microbial infection by producing 
cytokines and several immune modulators. Cytokines stimulate inflammatory events that 
activate effector mechanisms. These cytokines may directly or indirectly modulate 
periodontal destruction that involves the stimulation of bone resorption and induction of 
tissue degrading proteinases24. In fact microbial dental plaque starts periodontal disease but 
the form and severity of the disease is dependent on the environmental, genetic and host 
defenses to this challenge25. 
The role of the host response in periodontal bone loss is pivotal. There is evidence that an 
insufficient host response increases periodontal destruction and on the other hand a very 
strong response leads to periodontal disease26. A critical aspect of the host response is the 
detection of bacteria by Toll-like receptors (TLRs). Activation of the innate immune 
response by the binding of various bacterial components to TLRs results in the production 
of cytokines and chemokines27. The Toll-like receptors (TLRs) are a major class of 
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eukaryotic receptors for microbial pathogen associated molecular patterns (PAMPs)28 . They 
are expressed in a number of cell types, such as phagocytic cells, endothelial cells, 
fibroblasts, and inflamed periodontal tissues. When TLRs recognize PAMPs, alone or in 
homodimerization or heterodimerization with other TLR or non-TLR molecules, they 
induce signals responsible for the activation of genes relevant to the host defense including 
the inflammatory and adaptive immune- related cytokines29 . 
Toll receptor was originally identified in Drosophila as an essential receptor for the 
establishment of the dorsoventral pattern in developing embryos30 .  In 1996, Hoffmann’s 
group showed that Toll-mutant flies were more susceptible to fungal infection31 . Later, 
mammalian homologues of Toll receptor were identified one after another, and named as 
Toll-like receptors (TLRs). 13 members of the TLR family have been identified in mammals 
which 11 of them express at the protein level in humans.  TLRs are type I transmembrane 
proteins characterized by an extracellular domain containing leucine-rich repeats (LRRs) 
and a cytoplasmic tail that contains a conserved region called the Toll/IL-1 receptor (TIR) 
domain.  The structure of the extracellular domain of TLR3 was revealed by crystallography 
studies as a large horseshoe-shape32. TLR signaling consists of at least two distinct 
pathways, a MyD88-dependent pathway that leads to the production of inflammatory 
cytokines, and a MyD88-independent pathway associated with the stimulation of IFN-β and 
the maturation of dendritic cells. The MyD88-dependent pathway is common to all TLRs, 
except TLR3 33. TLRs responding to particular pathogens may activate complex networks of 
pathways and interactions, positive and negative feedback loops, and multifunctional 
transcriptional responses. Among the key downstream targets of these networks are NF-kB, 
mitogen-activated protein kinases, and members of the IRF family34. TLRs that detect 
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mainly extracellular microbial structures are expressed on the host cell surface (TLR-1, -2, - 
4, -5, -6), and TLRs that detecting viral or bacterial nucleic acids are  located intracellularly 
on endocytotic vesicles or organelles (TLR-3, -7, -8 ,-9)35. Also, TLRs has ability to 
heterodimerize within the family (e.g. TLR2 uses either TLR1 or TLR6 as signaling 
partners), or outside of TLR s family (e.g. TLR2 co- associates with CD14 or CD36). This 
ability might help to discriminate better among the abundant and diverse microbial 
structures36  . Crosstalk between complement and TLR signaling pathways has been shown 
which suggests that the complement–TLR interplay reinforces innate immunity or regulates 
excessive inflammation, through synergistic or antagonistic interactions37. 
Epithelial cells function as a physical barrier and in immune surveillance through their 
ability to elicit an innate immune response. TLRs are expressed predominantly in cells 
which mediate the first line of defense such as neutrophils, dendritic cells and 
monocytes/macrophages and in cells that are directly exposed to the outer environment such 
as epithelial cells38. 
Toll-like receptor 2 is involved in the recognition of peptidoglycans and lipoteichonic acid 
of Gram-positive bacteria39, 40. Also, TLR2 is specifically involved in the recognition of the 
periodontopathogenic bacteria Porphyromonas gingivalis38 . It was previously suggested that 
TLR 2 activity upon stimulation by P. gingivalis is related to the lipopolysaccharide41. Later 
It has been shown that TLR2 recognizes unknown cell wall components of P. gingivalis 
rather than the lipopolysaccharide itself42. It has been reported that TLR2 expression is 
higher in the gingival tissue of subjects with chronic periodontitis than in the gingival tissue 
of subjects with gingivitis43. Beklen et al. (2008), observed higher numbers of cells 
expressing TLR2 in the periodontitis tissue than in the healthy tissue44. Harokopakis and 
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Hajishengallis showed the evidence for TLR2 activation in response to the fimbriae of P. 
gingivalis which function in transmodulating the adhesive activities of human monocytes45. 
For many years, it was noted that everybody is not equally affected by the accumulation of 
bacterial plaque. Some individuals might be very susceptible and might develop aggressive 
forms of periodontitis at a relatively young age, while others might be resistant and never 
develop periodontitis13 . In some cases, the disease progression is slow, and the risk for loss 
of function of the teeth during a lifetime will be minimal, while in others it progress quickly. 
In addition, some gingival sites are more susceptible develop periodontitis than other 
gingival sites within the same subject.  The findings that high levels of inflammatory 
mediators such as IL-1, TNF and PGE2 are correlated with periodontal destruction 46 47  and 
that these mediators are able to aggravate the inflammatory response48   led to the hypothesis 
that some individuals may respond to periodontal infection with the production of high 
levels of inflammatory mediators, which in turn will result in attachment loss. Eskan et al. 
(2008), showed that Human gingival epithelial cells act differently in the expression of 
TLR4, and TLR4-normal HGECs produce four fold more IL-1β compare to the group of 
TLR4-deficient HGECs which induction of IL-1β plays an important role in mediating the 
release of other pro-inflammatory cytokines from primary human epithelial cells following 
challenge with P. gingivalis, and this process may be an inflammatory enhancement 
mechanism adopted by epithelial cells49. 
Experimental gingivitis studies show that there are variations among individuals in the rate 
of development of gingival inflammation. Wiedemann et al., (1979) reported that in a group 
of 62 who were subject to a period of withdrawal from oral hygiene, eight were ‘‘resistant’’ 
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and did not develop gingivitis within 21 days, while 25 subjects were ‘‘susceptible’’ and 
exhibited substantial gingival inflammation within 14 days. The remaining subjects formed 
an “intermediate” group50. Van der Velden showed that a group of subjects consistently 
exhibited greater than average gingival inflammation, while another group was always 
resistant51. Loe’s investigation in a Sri Lankan population without dental care and an 
absence of oral hygiene identified three sub-populations: a group with no progression of 
periodontal breakdown (11%), a group with moderate progression (81%), and a group with 
rapid progression (8%)52 . Van der Velden’s study in a remote village on Western Java who 
did not receive regular dental care reported that 20% of the population developed severe 
periodontal breakdown, but the rest of the population developed only minor to moderate 
breakdown53. 
Complex human diseases (for example Alzheimer disease, Crohns disease and 
cardiovascular diseases) present mostly a relatively mild phenotype, are slowly progressive 
and chronic in nature54 . These diseases are associated with variations in multiple genes, 
each of which has a small overall contribution and relative risk for the disease process. 
Complex diseases are typically polygenic, i.e. multiple genes each play a limited role (low-
penetrance genes), and the disease genes in these diseases considered as disease- modifying 
genes55 . Many studies have been done on the role of genes and their variants in host 
responses in periodontitis. The genetic polymorphisms may cause a change in the encoded 
protein, or its expression, and could alter innate and adaptive immunity, and may be 
deterministic in disease outcome56 . Evidence for the role of a genetic component in 
periodontitis has been investigated in family and twin studies. Van der Velden‘s study on 
young Indonesian siblings who did not receive regular dental care suggested that there may 
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be a genetic basis for the less severe forms of periodontitis57. Family studies may provide 
information on familiar aggregation, but they cannot distinguish between genetic and 
environmental influences. The twin model is probably the most powerful method to study 
genetic aspects of any disease, including periodontal disease. Michalowicz evaluated the 
periodontal condition of 110 adult twins and the results showed that between 38 and 82% of 
the population variance for these measures may be attributed to genetic factors58. In a study 
on 117 adult twin pairs, the analysis included evaluation of environmental factors such as 
smoking and utilization of dental services. The results showed that chronic periodontitis was 
estimated to have approximately 50% heritability, and this was unaltered following 
adjustments for behavioral variables59. Genetic variations linked to complex diseases are not 
easily identified in multifactorial traits. Single nucleotide polymorphisms (SNP) of the DNA 
are often used as genetic markers when they can be linked to a distinct phenotype. SNPs in 
receptors, antigen sensors in cell surfaces, and cytokines and chemokines have been shown 
to influence host immunity and inflammatory response60,61 . Periodontitis-related SNPs have 
been investigated in the Fc-gamma receptor, interleukin-1, IL-4, IL-6, IL-10, IL-18, TNFα, 
vitamin D receptor ,cluster of differentiation-14, matrix metalloproteinase-1, TLR-2, TLR4 
and COX-262 . 
There is a growing body of literature addressing the role of the environment on gene 
expression, but very little is known about the epigenetic pathways involved in the 
modulation of inflammatory and anti-inflammatory genes. Epigenetics, a relatively new 
concept in periodontitis research, may uncover the missing link between genetics, disease 
and environment. Epigenetics is described as changes in patterns of gene expression, which 
do not involve changes in the DNA sequence63. Epigenetics (as in “epigenetic landscape”) 
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was coined by C. H. Waddington in 1942 in the development context. Waddington did not 
use a specific definition for epigenetics (“All those events which lead to the unfolding of the 
genetic program for development”). By the mid-1980s it was clear that there was a new type 
of inheritance, not based on changes in DNA sequence. In 1987, Robbin Holiday wrote a 
paper “The inheritance of epigenetic defects”.  Holliday defined epigenetics as "the study of 
the mechanisms of temporal and spatial control of gene activity during the development of 
complex organisms64-66. 
Later, Epigenetics has been defined by  Riggs and colleagues as “ the study of mitotically 
and/or meiotically heritable changes in gene function that cannot be explained by changes in 
DNA sequence “ 67. In 2008, an agreement on the definition of the epigenetic trait was made 
at a Cold Spring Harbor meeting, “stably heritable phenotype resulting from changes in a 
chromosome without alterations in the DNA sequence”68. It has been founded that three 
important mechanisms provide the molecular basis of epigenetic regulation of gene 
expression. These are DNA methylation, histone modifications, and noncoding RNA 
(ncRNA)-mediated regulation. Also transvection, is also discussed as an epigenetic 
phenomena69.  
DNA methylation is a well-characterized epigenetic modification and it is also the most 
studied epigenetic mechanism in cancer70. It has been shown to play an important role in 
numerous biological processes, such as transposable element silencing, genomic imprinting 
(epigenetic process that involves DNA methylation and histone methylation in order to 
achieve mono-allelic gene expression without altering the genetic sequence)71 , X-
chromosome inactivation, and also in various disease processes including carcinogenesis. 
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DNA methylation is the addition of a methyl group to cytosines at the 5ʹ′ position of a CpG 
dinucleotide by a covalent modification which results in the formation of 5-methylcytosine 
(5mC), a base that changes the interactions between protein(s) and DNA. In mammalian 
cells, DNA methylation is a replication-dependent reaction catalyzed by DNA methyl 
transferases (DNMTs) which are present at the replication fork during the S-phase. CpG 
dinucleotides are typically rare and scattered throughout the genome and are fully 
methylated. However, DNA methylation also involves CpG-rich regions called ‘‘CpG 
islands’’ (CGIs)72. Approximately, 50% of human genes contain CpG islands and most of 
these islands are unmethylated in normal tissue73.  
           Figure 1 
                      
Conversion of cytosineto 5-methylcytosine by DNA methyltransferase (DNMT). DNMT catalyses thetransfer of a 
methyl group (CH3) from S-adenosylmethionine (SAM) to the 5-carbon position of cytosine. 
 
Unmethylated CpG islands are related to transcriptionally active structure, but methylated 
DNA recruits methyl-binding proteins such as MeCp2, which promotes interaction with 
histone deacetylases (HDACs). HDAC remove acetyl groups of histones leading to 
chromatin compaction and preventing the binding of transcription factors74, so gene 
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products are not expressed and many cellular functions might change by DNA methylation, 
including DNA repair, cell proliferation regulation and inflammatory gene expression75-77. 
Each tissue has a unique epigenetic profile, and changes occur as a result of developmental 
and regenerative processes.  For example there is clear evidence that embryonic stem cells 
have a unique epigenetic pattern that changes upon differentiation cues78. 
Studies show that extrinsic factors, such as hormones, regulate differentiation, and infection 
cause epigenetic modifications79. A similar effect can be achieved in the oral cavity, which 
is under the constant influence of extrinsic factors and foreign agents. Oral hygiene is 
naturally a contributing factor to oral health. Evidence shows that a lifestyle of smoking, 
food intake, lack of exercise, and use of drugs strongly influences the epigenetic pattern and 
predisposition to most conditions that lead to human disease80. Although epigenetic studies 
on the oral epithelium are very new, several studies suggest that these cells have ability to 
respond to environmental factors. The inflammatory response involves up-regulation of 
transcription factors like NF-kB and STAT, and epigenetic chromatin changes similar to 
other inflammatory diseases81 . Gingival tissues from periodontitis patients have been 
showed to have altered epigenetic patterns, particularly at inflammation-related genes. 
Alterations in the methylation pattern have been found in other oral diseases, such as 
squamous cell carcinoma82, tongue carcinoma83 and odontogenic keratocyst84. Olivera 
reported that the methylation pattern of the IL8 gene promoter in individuals with chronic 
periodontitis is altered when compared with healthy subjects85. 
The expression changes of some loci for example IFNG, occur as a result of the loss of 
methylation at their promoter86. On the other hand, Hodge et al. (2001) showed that the 
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overexpression of IL-6 is not associated with DNA methylation at its promoter, but IL-6 
upregulation may rather activate the DNMTs (DNA Methyltransferases), leading to 
methylation changes at the IL-6-induced target genes and development of a chronic 
inflammatory condition87. Zhang et al. showed that the TNFA promoter was 
hypermethylated at two CpG sites, resulting in decreased expression. By reversing the 
methylation by treatment with a demethylating agent in vitro, it caused increased expression 
of TNFA, indicating that the methylation indeed regulated the expression88. 
The evidence of epigenetic changes associated with periodontitis also comes from data on 
COX-2, an enzyme governing the production of prostaglandins that promote inflammation 
and pain. It has been reported that COX-2 inhibitors were able to reduce the symptoms of 
periodontitis patients89. On the other hand COX-2 expression in inflamed gingival tissues 
from chronic periodontitis patients was lower and its promoter was hypermethylated 90, 91. 
De Oliveria analyzed the status of DNA methylation in the promoter region of TLR2 and 
TLR4 genes in gingival tissue samples from healthy subjects, smokers and non-smokers 
affected by chronic periodontitis. The results showed major unmethylation of the TLR4 
gene promoter in all groups, but the results for the TLR2 gene promoter are inconclusive; 
this gene was found as a mosaic of methylated and unmethylated DNA in the majority of 
samples of the three groups and they also observed a trend towards the DNA methylation of 
CpG sites recognized by the HhaI enzyme92.                                                                                                             
Other epigenetic changes such as histone modifications also are involved in periodontitis. 
Treatment with HDAC inhibitors, such as 1179.4b and MS-275, on P. gingivalis-inoculated 
mice resulted in significantly reduced bone loss, indicating that maintenance of acetylation 
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is crucial to preventing bone loss93.  
While there are many signaling pathways that are affected in periodontitis disease state, 
there is limited knowledge of the involvement of epigenetics at the level of epithelium and 
this could shed light on heterogeneity in disease susceptibility.  Characterization of TLR2 
methylation status in gingival epithelial cells is highly significant as TLR2 is indispensable 
for TLR1 and TLR6 signaling and plays crucial role innate immune homeostasis.   
In this study we showed TLR2 CpG promoter methylation in periodontitis affected human 
gingival tissues and in primary human gingival epithelial cells chronically stimulated with 
P. gingivalis that may instigate epithelial dysbiosis that may create a unique pathogen niche 
in the gingival crevice and susceptibility to periodontitis.  
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Hypothesis Epigenetic	  variation	  in	  the	  gingival	  epithelial	  cells	  lead	  to	  the	  variation	  in	  	  the	  periodontal	  susceptibility.	  
 
Materials and Methods	  
 
Cell isolation and culture: 
The gingival tissue was obtained with Institutional Review Board (University of 
Pennsylvania) approval from patients who are admitted to periodontal surgery at the School 
of Dental Medicine. The tissue was treated with 0.025% trypsin and 0.01% EDTA overnight 
at 4°C, and keratinocytes were isolated 1.  Briefly, the cell suspension was centrifuged at 120 
× g for 5 min, and the pellet was suspended in K-SFM medium (Invitrogen CA) containing 
10 µg/ml insulin, 5 µg/ml transferrin, 10 µM 2-ME, 10 µM 2-aminoethanol, 10 mM sodium 
selenite, 50 µg/ml bovine pituitary extract, 100 U/ml penicillin/streptomycin, and 50 ng/ml 
fungizone (complete medium). The cells were seeded in 60-mm plastic tissue culture plates 
coated with type I collagen, and incubated in 5% CO2 and 95% air at 37°C. When the cells 
reached sub-confluence, they were harvested and sub-cultured 2. 
 
Cell challenge assays: 
HGECs at the 3rd passage were harvested, seeded at a density of 0.5 × 105cells/well in 6 well 
culture plate coated with type I collagen and maintained in 2 ml of complete medium as 
described above. When the cells reached ~95% confluence the cells were stimulated with P. 
gingivalis (MOI:10).  Culture supernatants were collected at the end of the experiment and 
stored at -80°C until being assayed.  Production of IL-1β and TNF were measured using 
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ELSA kits (BD Biosciences, CA).  For in vitro chronic infection model (Figure 2), P. 
gingivalis at MOI:5 was stimulated for 30 minutes and washed with plain medium and 30 
minutes stimulation cycle was carried out at 4 h, 8 h and 16 h.  After 48 h from the first 
infection cycle, the cells were split and seeded equally.  When these cells reached ~50% 
confluence, the cells were exposed to one more round of P. gingivalis stimulation either in 
the presence or absence of DNMT inhibitor. After 48 hours of first stimulation, the DNA 
was extracted and purified using QIAamp DNA isolation kit (Qiagen, CA), Lysis by 
Protease K followed by purification on spin column. The extracted DNA was subjected to 
methylation qPCR using methylation specific primers from SAbiosciences, CA according to 
manufacturer’s instruction. 
          Figure 2 
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Transfection: 
Primary epithelial cultures at the fourth passage were harvested, seeded at a density of 
0.5x105 cells/well in a 6 well culture plate coated with type-I collagen, and maintained in 2 
ml of medium until they reached ~70% confluency. The epithelial cells were transfected 
with 100 pmol of pcDNA3-TLR2 and empty vector using GenMute transfection reagent 
according to manufacturer’s instruction (SignaGen, MD).  The plasmids were mixed with 
GenMute transfection reagent by pipetting up and down and incubated for 15 minutes at RT 
to let transfection complex form.  The mixture was then added drop wise on to the cells and 
Gently rocked the plate back and forth. Transfection reaction was carried out for 24 h.  After 
24 h, the cells were challenged as mentioned above. 
Real-time PCR:   
Total RNA was extracted from cultured cells by using TRIzol reagent (Invitrogen, Carlsbad, 
CA). TRIzol reagent has been added directly to the culture dishes to lyse the cells and cell 
lysate has been passed through a pipette several times. The Homogenization phase has been  
followed by Phase Separation, RNA Precipitation, RNA Wash and re-dissolving the RNA. 
The isolated total RNA samples were used to perform first strand cDNA synthesis (Applied 
Biosystems, Foster City, CA). Real-time PCR was performed by using 50ng of cDNA, 
primers and probes and GAPDH as endogenous control on ABI 7500 Fast system (Applied 
Biosystems) in the presence of TaqMan DNA polymerase3. Quantitative TaqMan PCR-
Array was custom designed based on previously published microarray data on keratinocytes 
4.  The cDNA conversion and real time PCR were carried out as mentioned above.  The fold 
increase was calculated as compared to untreated control sample according to ΔΔCT method 
5.  Mean fold increase data was used to derive heatmap with two-way hierarchical clustering 
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using MeV v4.1 software.   
Methylation qPCR: 
The genomic DNA was subjected restriction digestion using EpiTect Methyl II DNA 
restriction kit (SAbiosciences, CA. The reaction mixture consisting of methylation sensitive 
and methylation dependent restriction enzymes were incubated for 6 hours at 37°C. After 
which, the reaction was terminated and enzyme was inactivated at 65 °C for 20 minutes.  
The digested DNA samples were subjected to real time PCR using TLR2 promoter CpG 
discriminating primers from SAbioscienes, CA.  The percent methylation was calculated 
using data analysis software from Orion Genomics, LLC.    
The method employed by the EpiTect Methyl II PCR System is based on detection of 
remaining input DNA after cleavage with a methylation-sensitive and/or a methylation-
dependent restriction enzyme. These enzymes will digest unmethylated and methylated 
DNA, respectively. Following digestion, the remaining DNA in each individual enzyme 
reaction is quantified by real-time PCR using primers that flank a promoter (gene) region of 
interest. The relative fractions of methylated and unmethylated DNA are subsequently 
determined by comparing the amount in each digest with that of a mock (no enzymes added) 
digest using a ΔCT method. The reliability and simplicity of the procedure make this 
technology highly suited for semi-high–throughput DNA methylation profiling and 
biomarker development for various research fields, such as stem cell differentiation and 
development. Input genomic DNA is aliquoted into four equal portions and subjected to 
mock (no enzyme), methylation-sensitive (MSRE), methylation-dependent (MDRE), and 
double (MSRE and MDRE) restriction endonuclease digestion. After digestion, the enzyme 
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reactions are mixed directly with qPCR master mix and are dispensed into a PCR Array 
plate containing pre-aliquoted primer mixes. Real-time PCR is carried out using specified 
cycling conditions. Finally, the raw ΔCT values are pasted into the data analysis 
spreadsheet, which automatically calculates the relative amount of methylated and 
unmethylated DNA fractions. The product of the mock (no enzyme) digestion represents the 
total amount of input DNA for real-time PCR detection. In the methylation-sensitive 
digestion (Ms) reaction, the MSRE will digest unmethylated and partially methylated DNA. 
The remaining hypermethylated DNA — DNA in which all CpG sites are methylated — 
will be detected by real-time PCR. In the methylation-dependent digestion (Md) reaction, 
the MDRE will preferentially digest methylated DNA. The remaining unmethylated DNA 
will be detected by real-time PCR. In the double digestion (Msd) reaction, both enzymes are 
present, and all DNA molecules (both methylated and unmethylated) will be digested. This 
reaction measures the background and the fraction of input DNA refractory to enzyme 
digestion (Figure 3). 
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       Figure 3 
                         
 
 
Bisulfite treatment and sequencing:  
The methylation status of a DNA sequence can be determined using sodium bisulfite. 
Incubation of the target DNA with sodium bisulfite results in conversion of unmethylated 
cytosine residues into uracil, leaving the methylated cytosines unchanged. Therefore, 
bisulfite treatment gives rise to different DNA sequences for methylated and unmethylated 
DNA. The most critical step for correct determination of a methylation pattern is the 
complete conversion of unmethylated cytosines. This is achieved by incubating the DNA in 
high bisulfite salt concentrations at high temperature and low pH.  
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Figure 4
 
 
These harsh conditions usually lead to a high degree of DNA fragmentation and subsequent 
loss of DNA during purification. Purification is necessary to remove bisulfite salts and 
chemicals used in the conversion process that inhibit sequencing procedures. Common 
bisulfite procedures usually require high amounts of input DNA. However, due to DNA 
degradation during conversion and DNA loss during purification, such procedures often lead 
to low DNA yield, highly fragmented DNA, and irreproducible conversion rates.  
In figure 5 as an example, DNA with methylated CmpG at nucleotide position #5 was 
processed using the EZ DNA MethylationTM Kit. The recovered DNA was amplified by 
PCR and then sequenced directly. The methylated cytosine at position #5 remained intact 
while the unmethylated cytosines at positions #7, 9, 11, 14 and 15 were completely 
converted into uracil following bisulfite treatment and detected as thymine following PCR. 
       
	   31	  
Figure 5
 
In our study the bisulfite conversion was done using EZ DNA methylation Gold kit from 
Zymoresearch Inc.  Briefly, 500 ng of genomic DNA was mixed with 130 µl of CT 
conversion reagent and the reaction was carried out on a thermal cycler (98°C for 10 
minutes, 64° C for 2.5 hours).  After the reaction, the product was washed using Zymo-spin 
column and desulphonated using M-Desulphonation buffer for 20 minutes at room 
temperature.  The desulphonated product was purified according to manufacturer’s 
instructions.  The promoter sequence of TLR2 was obtained from Transcriptional Element 
Regulatory Database (Cold Spring Harbor Laboratory, USA).  The CpG Island screening, 
bisulfite specific primer and methylation specific primers were designed using Mehtyl 
primer express v1.0 software (Lifetechnologies, CA).  The primer sequences are as follows: 
methylation sensitive forward primer  -TTTTGTACGGGGTAGTTGTC; reverse primer 
 -ACTACGCTTTCTCGCTACC and non-methylation forward primer         
AGTTTTGTATGGGGTAGTTGTT; reverse primer -ACTACACTTTCTCACTACCTC.  
The bisulfite converted DNA was amplified using the above primer pairs and ZymoTaq hot 
start DNA polymerase (Zymoresearch Inc., CA).  This generated product size of 295 bp 
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within promoter CpG Island.  The PCR product was purified using DNA clean and 
concentrator kit and sequenced at Penn Genomic Core, University of Pennsylvania, PA.  
The sequence obtained was analyzed using BISMA program6.  
 
Experimental Periodontitis, Oral gavage mouse model  
 
Periodontitis was induced in 6-8 week-old BALB/c mice by oral inoculation with P. 
gingivalis ATCC 33277 by means of a ball-ended feeding needle. Briefly, upon suppression 
of the normal oral flora with antibiotics (Mice were given sulfamethoxazoletrimethoprim at 
10 ml per pint in deionized water ad libitum for 10 days. This was followed by a 3-day 
antibiotic-free period), mice were orally infected five times at 2-day intervals with 109 CFU 
P. gingivalis suspended in 2% carboxymethylcellulose/PBS. Sham-infected controls 
received 2% carboxymethylcellulose/PBS alone. The mice were euthanized one month after 
the last oral inoculation. Assessment of periodontal bone loss in defleshed maxillae was 
performed under a dissecting microscope (x40) fitted with a video image marker 
measurement system (VIA-170K; Boeckeler Instruments). Specifically, the distance from 
the cement enamel junction (CEJ) to the alveolar bone crest (ABC) was measured on 14 
predetermined points on the buccal surfaces of the maxillary molars to sham controls. 
Gingival  tissue samples has been excised and DNA has been extracted for TLR2 promoter 
methylation analysis. 
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Results 
 
 
TLR2 gene expression heterogeneity in human gingival epithelial cells 
Having identified the importance of TLRs in gingival epithelial cells mounting innate 
immune responses correlated to gingivitis and periodontitis, we noted that TLR2 gene 
expression in primary human gingival epithelial cells (HGECs) upon P. gingivalis 
stimulation showed variability within gingival epithelial cells isolated from different 
patients. We defined the group of HGECs which induced relatively higher level of TLR2 
gene expression following challenge with P. gingivalis as TLR2-normal cells. The detected  
HGECs with reduced TLR2 expression at mRNA levels has been named TLR2-
dysregulated cells (Fig. 6A). Epithelial cells with relatively lower TLR2 expression also 
secrete low levels of cytokines and antimicrobial peptides. The normal cell type upregulated 
both proinflammatory cytokine and antimicrobial peptides, however, the dysregulated type 
cells with lower TLR2 expression in response to P. gingivalis also exhibited blunted 
cytokine and antimicrobial peptide response (Fig.6 B, C). Hence, we hypothesized that 
blunted TLR2 expression might be epigenetically regulated leading to altered TLR2 mRNA 
expression and subsequently pro-inflammatory cytokines, consequently leading to epithelial 
“dysregualted” phenotype in humans. 
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Figure 6 
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Fig 6: Isolated human primary gingival epithelial cells were cultured and stimulated with P. gingivalis at 
MOI:10 for 4 hours.  The cDNA was subjected to realtime PCR using TLR2 TaqMan probe.  The relative 
expression of TLR2 was calculated using GAPDH as endogenous control (A). The cDNA from three 
individuals from each group was subjected gene expression analysis using TaqMan probes. The ΔΔCT values 
were used to generate heatmap based on two-way hierarchical clustering with MeV v4.1 software 
(rows=genes, columns=sample). The color scale indicates relative expression: yellow, above mean (>3.0); 
blue, below mean (0.0); and black, unchanged (1.0) (B). The data is mean of two independent experiments. 
Production of IL-1B was assayed with ELISA(C) 
 
 
TLR2 promoter methylation in dysregulated gingival epithelial cell type 
Since we observed blunted inflammatory response in dysregulated cells with P. gingivalis 
stimulation and P. gingivalis is a known agonist for TLR2 and TLR4 3, 7, 8, we carried out 
TLR pathway DNA methylation PCR (SAbiosciences, CA) to determine if there is 
epigenetic deregulation at the promoter level in TLR signaling network.  The DNA sample 
was isolated from representative dysregulated cell type and subjected to methylation 
specific enzyme digestion.  After the digestion, the real time PCR was carried out and data 
was analyzed according to manufacturer’s instruction (SAbiosciences, CA). 26 genes 
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showed promoter methylation with TLR2 higher promoter methylation in dysregulated cell 
type (Fig. 7). Dysregulated cells has been shown three fold more methylation of TLR2 
promoter than normal cells group (Fig 8)  
                  Figure 7 
 
 
 
 
 
 
 
 
 
 
Fig 7: Promoter DNA methylation in dysregulated cells epithelial cells:  The DNA from dysregulated 
epithelial cells were subjected to toll-like receptor signaling pathway DNA methylation PCR arrays from 
SAbiosciences, CA.  The data was analyzed using EpiTect methyl II PCR data analysis program and 
methylation is represented as percent compared to unmethylated DNA standard.  TLR2 exhibited hyper-
methylation in dysregulated cells (dotted circle)	  
 
 
 
Chronic treatment of P. gingivalis induce de novo methylation in TLR2 
promoter 
 
 
In an attempt to mimic chronic infection status and in our quest to understand how the 
bacteria changes methylation profile of epithelial cells, we developed a system called 
“chronic in vitro infection model” (Fig. 2).  The time points were chosen based on our Lab’s 
previously published results on P. gingivalis induced inflammatory cytokine response in 
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gingival epithelial cells 2,7, 8,9,10.  By using this method, we successfully induced tolerance to 
P. gingivalis (live bacteria at MOI:5 ) in ‘normal’ epithelial cells. The chronic infection was 
done according to following method.  P. gingivalis (MOI:5) stimulation was initially carried 
out for 30 minutes at 0, 4, 8 and 16 h time intervals.   After 48 h from the last stimulation, 
the cells were split and re-exposed to the P. gingivalis stimulation cycle in the presence or 
absence of 1 µM of 5-Aza-2’-deoxycytidine (decitabine) and evaluated for the TLR2 
promoter methylation status.  After which, DNA samples were subjected TLR2 promoter 
methylation PCR (SAbiosciences, CA) Repeated stimulation with P. gingivalis induced 
reprogramming of TLR2 region by inducing de novo methylation.  By using decitabine we 
were able to essentially eliminate the TLR2 promoter methylation that was induced by P. 
gingivalis (Figure 8). 
           Figure 8  
                               
Fig 8: In vitro chronic infection model: The DNA was extracted at the end of above experiment and subjected 
to TLR2 DNA methylation sensitive qPCR using TLR2 methylation primers (SAbiosciences, CA).  The data is 
represented as percent methylation compared to unmethylated standard DNA. Chronic P. gingivalis infection 
induced de novo methylation in HGECs.   
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Reconstitution of TLR2 rescue dysregulated epithelial cells 
As we noted blunted TLR2 expression in dysregulated epithelial cells, we wanted to 
overexpress TLR2 by transfecting TLR2 overexpression vector in dysregulated cells type.  
TLR2 overexperession plasmid (Addgene, MA) and empty vector was transfected using 
GenMute transfection reagent (SignaGen Laboratory, MD) and incubated the cells.  After 24 
hours of transfection, the cells were stimulated with P. gingivalis (MOI:10) for 4 hours and 
total RNA was subjected to real time PCR against TLR2 and IL-1β.  The data showed that 
the overexpression of foreign TLR2 can rescue inflammatory response to P. gingivalis (Fig. 
9).   
   
    Figure 9 
 
 
Fig 9: TLR2 overexpression up-regulates inflammatory cytokine in dysregulated cells: The dysregulated cells 
were transfected with a plasmid overexpressing TLR2 (Addgene, MA).  After 24 h post transfection, the cells 
were stimulated with P. gingivalis and cDNA was subjected to TLR2 and IL-1β mRNA expression using 
TaqMan probes.  TLR2 overexpression showed up-regulation of IL-1β induction after P. gingivalis stimulation 
in dysregulated cells.   
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DNA methyltransferase inhibitor rescue inflammatory response in 
dysregulated cells 
 
 
As a therapeutic approach, we wanted to test if the dysregulated cells can be modified to 
express TLR2  by targeting DNA methyltransferase in HGECs. The dysregulated epithelial 
cells were cultured with DNA	  methyltransferase	  (DNMT) inhibitor at a concentration of 1 
µM before stimulating with P. gingivalis for 4 hours.  After stimulation, the total RNA was 
extracted and subjected to real time PCR using TLR2 and TNF TaqMan probes 
(Lifetechonologies, CA).  The real time PCR data showed that DNMT inhibitor can restore 
TLR2 expression in dysregulated epithelial cells and induce inflammatory response to P. 
gingivalis . This clearly shows that DNMT as a therapeutic target in restoring inflammatory 
response to a pathogen in dysregulated epithelial cell types and DNMT inhibitor may serve 
as therapeutic agent against periodontitis (Fig.10). DNA	  methyltransferase	  inhibitor	  could	  rescue	  TLR2	  and	  TNFα	  expression	  in	  “dysreglated”	  epithelial	  cells.	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Figure 10 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig 10: DNA methyltransferase inhibitor rescue TLR2 expression in dysregulated epithelial cells: The 
dysregulated epithelial cells were cultured in the presence of 1 µM 5-Aza-2’-deoxycytidine (Sigma-Aldrich, 
USA).  When it reached 90% confluence, the cells were split and cultured on 6 well plates in the presence of 5-
Aza-2’-deoxycytidine.  At 90% confluence, the cells were stimulated with P. gingivalis at MOI:10 for 4 hours 
and cDNA was subjected to real time PCR using TLR2, TNF and GAPDH probes.  The data represented as 
mean standard error from three independent experiments. 
 
 
TLR2 promoter methylation in periodontal disease affected tissue in 
mouse model 
To test the change of TLR2 promoter methylation level following periodontitis, a gavage 
experimental periodontitis model in mouse has been designed. DNA isolated from the 
gingival tissue of sham and periodontitis group have been analyzed to compare the 
methylation percentage. The gingival tissue obtained from the periodontitis group showed 
higher percentage of methylated TLR 2 promoter than the control group. 
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Figure 11
 
Fig11: TLR2 promoter methylation in periodontal disease affected tissue in mouse model: Periodontitis was 
induced in 6-8 week-old BALB/c mice by oral inoculation with P. gingivalis ATCC 33277. The gingival tissue 
obtained from the periodontitis group showed higher percentage of methylated TLR 2 promoter than the 
control group. 
 
 
TLR2 promoter methylation in periodontal disease affected tissue 
Next, we wanted to examine whether this phenomena exist in patients with periodontitis.  
To confirm this, we obtained gingival tissue from periodontitis affected site and healthy site 
from patients who are undergoing flap surgery from the periodontics clinic.  This tissue was 
subjected to genomic DNA isolation and purification using QIAamp DNA kit (Qiagen, CA).  
1 µg of isolated genomic DNA was subjected to bisulfite conversion using EZ DNA 
methylation gold kit (Zymo Research, CA).  The converted samples were desulphonated and 
purified according to manufacturer’s instructions.  2 µl of elute was used was then subjected 
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to PCR using bisulfite primers designed using Methyl Primer Express Software v1.0 
(Lifetechnologies, CA).  The amplified samples were sequenced using dye termination 
method.  The DNA sequence obtained was exported to BISMA program12.  The sequence 
analysis showed TLR2 promoter methylation in the disease tissue site.  This clearly 
indicates that there is host epigenetic regulation at the periodontitis disease affected tissue. 
 
Figure 12 
   
 
Figure 12: TLR2 promoter CpG targeted bisulfite DNA sequencing: Healthy and periodontitis-affected tissue 
was collected and subjected to bisulfite treatment (Zymo Research Inc., CA).  After bisulfite treatment, the  
DNA was subjected to bisulfite sequencing.  The sequence data was analyzed using BISMA software program. 
Disease site showing TLR2 promoter CpG methylation (dotted box). 
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Discussion 
 
Periodontal disease is initiated by a microbial biofilm of ~700 different microorganisms 
most of which are Gram negative anaerobic bacilli13,14.  Among these, an important putative 
pathogen is Porphyromonas gingivalis and is now regarded as “key-stone pathogen”15, 16.  P. 
gingivalis is recognized by toll-like receptors, TLR2 and TLR4 17 and their activation is a 
crucial step in developing an innate immunity to pathogenic microorganisms.  The activated 
host innate immune defense is characterized by elevated cytokine production following 
bacterial perturbation. Successful triggering of cytokine production is considered 
homeostatic. Accordingly, the induction of inflammatory cytokines must be tightly 
regulated and multiple regulatory mechanisms control the duration of TLR induced 
inflammation18. One such control could be at the level of TLR expression itself where 
blunted TLR expression could lead failure of proper innate immune response.  
We observed a blunted pro inflammatory and antimicrobial response to P. gingivalis 
stimulation in periodontitis affected persons’ gingival epithelial cells.  In gingival epithelial 
cells, TLR2 is expression is higher than that of TLR411.  Hence we sought to understand the 
mechanism of TLR2 gene expression variation in these cells. 
 It has been shown that genetic factors are very important in the development of 
periodontitis. Some Single nucleotide polymorphisms (SNPs) and single nucleotide 
variations (SNVs) alter gene expression levels that may influence host response levels to 
microbiological growth. For example, SNPs in receptors, antigen sensors in cell surfaces, 
and cytokines and chemokines have been shown to influence host immunity and 
inflammatory response19,20. The most common polymorphism is a transition from a C to a T 
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nucleotide. These polymorphisms can affect numerous CpG sites in the genome, by altering 
a C in a CpG dinucleotide to another nucleotide that cannot be methylated21. Studies have 
shown that these SNPs can influence gene expression via effects on DNA methylation. The 
effect of SNPs on DNA methylation can either be direct, by changing a C (in a CpG 
dinucleotide) to a non-modifiable nucleotide, or indirect by altering transcription factor 
binding, which in turn independently affects gene expression and DNA methylation levels 
22,23. 
 It is important to understand that the levels of transcripts, proteins and metabolites may 
reflect not only the genetic programming, but also the consequences of response to 
environmental factors and disease progression. There are layers of chemical modifications 
on the DNA and its associated proteins that regulate gene expression. Recent studies in 
understanding genetic variation implicated not only Mendelian inheritance but also non-
Mendelian inheritance termed “epigenetics”24,25. Epigenetics has been linked to many 
diseases including cancer and inflammation 26. There have been numerous studies in humans 
relating to variation caused by epigenetic changes with respect to aging 27-29. DNA 
methylation and histone modification are the two major mechanisms of epigenetic 
alterations observed in human cells, and both mechanism block the transcriptional factors. 
studies have demonstrated that epigenetic events are able to influence the production of 
cytokines contributing to the development of diseases, such as airway inflammation and 
severe systemic inflammation24,30 . 
The post-translational histone modifications, such as acetylation/de-acetylation, methylation 
and phosphorylation, could play its epigenetic role in the organization of chromatin domains 
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and the up or down regulation of gene expression. Recent	  studies	  have	  demonstrated	  that	  acetylation	   of	   core	   histone	   is	   associated	   with	   cardiovascular	   diseases31. Also 
accumulating evidences points towards association of aberrant DNA methylation in the 
development of various human diseases31. Altered DNA methylation predicted Crohn’s 
disease status where key host defense mechanisms including TH17 were dysregulated 32.  
There is evidence of crosstalk between DNA methylation and histone modifications. It is not 
known how cross‐talk between these two systems is mediated, but in at least some 
circumstances, changes to histone modifications may be induced prior to methylation 
changes that then serve as more stable epigenetic marks33 . 
 Accumulating evidences points towards association of aberrant chromatin methylation in 
the development of various human diseases34. With this background we set out to test 
dysregulated and normal epithelial cells for changes in their CpG island methylation pattern 
on the promoter region of genes involved in the TLR inflammatory pathway. Importantly, 
we noted a highly methylated CpG promoter region in the TLR2 gene in dysregulated cells. 
These cells induced diminished pro-inflammatory cytokines and antimicrobial peptide in 
response to P. gingivalis.  In support of blunted inflammatory response in dysregulated 
epithelial cells, siRNA against TLR2 had similar effect in normal cells in response to P. 
gingivalis. This innate immune compromise within epithelial cells may direct effect on 
antimicrobial defense as well as indirect influence on adaptive immune responses such as 
inhibition of IL-12 from T cells that facilitate P. gingivalis persistence35.   
The epigenetic changes can be induced by repeated bacterial ligand challenge (E. coli LPS) 
as shown in murine macrophages leading to tolerance in cells with blunted cytokine 
	   46	  
responses36,37. ENCODE project (www.genome.ucsc.edu/ENCODE) supports our data of 
differential TLR2 methylation status, where, one CpG Island on TLR2 gene was revealed 
with differential CpG methylation across different cells lines. Moreover, CpG island 
hypermethylation in gene promoters has been shown to be an important mechanism in gene 
silencing37. The changes pertaining to epigenetics may be brought about by age related 
methylation 38 or changes that occur due to chronic inflammation as in ulcerative colitis due 
to constant turnover of cells39. Helicobacter pylori is known to be associated with the 
accumulation of aberrant DNA methylation in gastric epithelial mucosa40. LPS derived from 
P gingivalis has been demonstrated to inhibit osteoblastic differentiation of osteoprogenitor 
cells derived from fatal rat calvaria41. Recently, bacterial induced hypermethylation of Igf2 
gene has been revealed42. It is possible that similar mechanisms exist for different 
pathogens.  In humans, with chronic periodontitis, hypermethylation pattern of the promoter 
of Prostaglandin-endoperoxide synthase 2 (PTGS2) is altered43. This study also showed that 
certain genes possess ‘hot spots’ for epigenetic changes leading to silencing of certain 
genes. Nevertheless, P. gingivalis inducing DNA methylation is relevant because of the 
nature of the bacteria and its pathogenic effect in periodontal disease pathology. 
The identification of TLR2 DNA methylation status in periodontitis affected tissue samples 
supported our in vitro data.  However, this tissue comprised not only of epithelial cells but 
also other type of cells.  Further investigation with regard to gingival tissue is needed 
especially using laser scanning micro-dissection to isolate epithelial cells and to determine 
their methylation status.  We are also aware of the fact that the data needs to be validated 
using in vivo experimental periodontitis model. Although we just tested one of the 
epigenetic alteration mechanism, Cytosine Hyper methylation, we know that other 
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Chromatin epigenetic modification like Histone changes might have effect on this 
phenomena. Nonetheless, our data clearly indicates that epigenetic modification in gingival 
epithelial cells plays an important role in gene silencing pushing the cells to a hypo-
responsive state thereby failing to restrain harmful chronic inflammation.  
 
 
Conclusion 
Within the limitation of this study, our data suggest that epigenetic modifications of the 
TLR2 promoter region play an important role in inducing the hypo-responsive phenotype in 
dysregulated cells that can lead to failure of host defense mechanisms.  The use of DNA 
methyltransferase inhibitor that restored dysregulated cells cytokine response shows 
therapeutic potential.  Overall, it is plausible that the differences in epigenetic signatures on 
pattern recognition receptors may help explain periodontitis disease susceptibility. 
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